ReviewDiagnostics (Basel, Switzerland)2021

Dolutegravir Plus Lamivudine Two-Drug Regimen: Safety, Efficacy and Diagnostic Considerations for Its Use in Real-Life Clinical Practice-A Refined Approach in the COVID-19 Era.

Valeria Cento et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.